AMINO ACIDS, BRANCHED-CHAIN
Liver Transplant
University of ArkansasmixtureN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
5 Active assets in the Liver Transplant cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
CYCLOSPORIN A Novartis Pharmaceuticals | Phase 4 | B |
Bms-907351 University Health Network, Toronto | Phase 2 | CCC |
LENVATINIB Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 1/2 | CCC |
Rivoceranib Zhejiang University | Phase 1/2 | CC |
FLUOROURACILUM Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 1/2 | CC |
Calcium folinate pentahydrate Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 1/2 | CC |
Eloxatin Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 1/2 | CC |
Same molecule, other indications
AMINO ACIDS, BRANCHED-CHAIN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →